Q-Pulse helps Symbiosis Pharmaceutical Services gain MHRA licence
Symbiosis Pharmaceutical Services is a leading small-scale contract manufacturer of novel injectable pharmaceuticals for use in clinical trials. The company specialises in the phase I and phase II GMP manufacture of liquid, lyophilized, cytotoxic, conventional and biological pharmaceuticals.
As an MHRA licence was required for Symbiosis to begin manufacturing, the company set out to put in place a quality management system to manage compliance activities such as document control, auditing and corrective and preventive actions.
Q-Pulse, from Ideagen, was implemented to help them secure their MHRA licence, allowing Symbiosis to manufacture their products.
- Q-Pulse helped Symbiosis achieve MHRA accreditation, with the product now embedded into the company & enabling them to stand up to other regulatory audits
- Organisational documentation now managed in a centralised, electronic register complete with managed document approval and review workflows
Q-Pulse is more than a contribution to our quality system - it IS our quality system.